• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STIMWAVE TECHNOLOGIES INC. FREEDOM NEUROSTIMULATOR; SPINAL CORD NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STIMWAVE TECHNOLOGIES INC. FREEDOM NEUROSTIMULATOR; SPINAL CORD NERVE STIMULATOR Back to Search Results
Model Number FR8A-SPR-B0
Health Effect - Clinical Code Electric Shock (2554)
Date of Event 11/23/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
For the report of loss of therapy: the perm - loss of therapy/no therapy questionnaire was reviewed for potential causes of the reported issue.Based on this review, implanting the device in an off-label location and no attempts to reprogram the waa were ruled out as potential causes of the reported issue.Other potential causes of loss of therapy/no therapy are stimulator placement too close to the nerve, improper stimulation parameters, stimulator damage during/before implant procedure, patient co-morbidities, and patient expectations.Migration was ruled out via x-ray.For the report of shock: the clinical representative reported the patient stated experiencing an occasional shocking sensation due to the programmed amplitude being set too high.The clinical representative reduced the amplitude and the patient is receiving minimal relief, but is no longer experiencing the shocking sensation.Potential causes of shock/unintended stimulation include stimulation parameter settings, stimulator placement too close to the nerve, mri induced stimulation, implanting the stimulator too close to the nerve, stimulator electrical failure and interference from other electro magnetic sources.The waas were not returned as they appear to be functioning as expected and the rep will continue with standard reprogramming to establish therapy.The stimulator is used to treat pain.The cause of loss of therapy is unknown.However, the cause of the overstimulation/shocking sensation is likely due to incorrectly programmed waa stimulation parameters (user error - clinical representative).
 
Event or Problem Description
On (b)(6) 2021, the patient reported a loss of therapy.The stimwave clinical representative attempted reprogramming the waa to re-establish pain relief.When the clinical representative increased the amplitude of the programming parameters, the patient reported feeling a shocking sensation.The shocking sensation experienced by the patient was reported by the clinical representative to stimwave quality on (b)(6) 2022.The patient is currently receiving minimal relief.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREEDOM NEUROSTIMULATOR
Common Device Name
SPINAL CORD NERVE STIMULATOR
Manufacturer (Section D)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer (Section G)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer Contact
alicia pagliaro
1310 park central boulevard s.
pompano beach, FL 33064
MDR Report Key13514298
Report Number3010676138-2022-00019
Device Sequence Number4207700
Product Code GZB
UDI-Device Identifier00818225020648
UDI-Public010081822502064817230501
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K171366
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 02/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date05/01/2023
Device Model NumberFR8A-SPR-B0
Device Lot NumberSWO210530
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/23/2021
Initial Report FDA Received Date02/11/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
WAA (PDBT-915-2K), SN: (B)(4); WAA (PDBT-915-2K), SN: (B)(4)
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-